Duofortuna Therapeutic INC
- Biotech or pharma, therapeutic R&D
DuoFortuna Therapeutic Inc., founded in 2020, is an AI-driven drug discovery company specializing in first-in-class small molecule therapeutics. Its proprietary platform integrates forward/reverse AI screening, druggability prediction, and chemical–protein interaction modeling. Key assets include a virtual library of 4.2B compounds, a 250,000-entry co-crystal protein structure database, and a reverse docking engine for all FDA-approved drugs. DuoFortuna excels at discovering potent, drug-like compounds for targets lacking known crystal structures, achieving 20–30% hit rates and nanomolar affinities in preclinical assays. The platform enables zero-to-one breakthroughs in first-in-class drug discovery. We are actively seeking global partners for licensing, co-development, and strategic R&D collaboration.
Address
SuzhouChina
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}